# Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

> **NCT06914674** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 30 (estimated)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **DRUG:** Tamoxifen 20 mg

## Key facts

- **NCT ID:** NCT06914674
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-20
- **Primary completion:** 2027-02-28
- **Final completion:** 2028-02-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914674, "Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06914674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*